The Bronchodilator Drugs market in Central America is anticipated to witness a significant growth in revenue, with projections indicating that it will reach US$46.90m by 2024. Moreover ...

A new study reveals that ensifentrine, a novel COPD treatment, significantly reduces COPD-related healthcare usage over 48 ...

Clenbuterol has not been approved by the U.S. Food and Drug Administration (FDA) as an ingredient for any drugs for humans, ...

The Bronchodilator Drugs market in Puerto Rico is anticipated to witness a significant growth in revenue, with projections indicating that it will reach a staggering US$10.15m by 2024. This ...

This study highlights the benefits of anti-inflammatory inhalers in asthma management, showing reduced complications and ...

Do cough, cold or other respiratory issues disrupt your sleep in the rising air pollution? Explore the best nebulizer ...

Trials using oral dosing of labeled and unlabeled drug have demonstrated that the ... Patients included those inadequately controlled with bronchodilators alone (Trial 1), those already receiving ...

The FDA announced on Thursday a proposed order to remove oral phenylephrine as an active ingredient in over-the-counter (OTC) ...

The drug was administered twice-daily using a ... phosphodiesterase 3 and 4 (PDE3 and PDE4), and is thought to combine bronchodilator and anti-inflammatory properties in one compound.

Asthma treatment costs the NHS millions each year, with inhalers being a significant part of this expenditure. Dr. Potter highlighted the wide range of inhalers available, from basic bronchodilators ...

Rubaab, an 8-year-old Noida student living in Delhi, has been using a nebuliser ever since he was a toddler. A nebulizer is a ...